The lncRNA RP11-369C8.1 produces six splice variants, two of which (TRMP and TRMP-S) have been characterized to promote the growth of cancer cells by modulating cell cycle progression through distinct mechanisms of action (38, 39). Here, LINC02303 is linked to cancer.